$VICR

VINCIARELLI PATRIZIO sold $507K of VICR

VINCIARELLI PATRIZIO (Chairman and CEO) sold 1,600 shares of VICOR CORP (VICR) at $316.98 ($0.51M total) on 2026-06-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published Jun 5, 2026, 4:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 5, 2026, 4:21 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The disclosure provides a fresh, dated insider activity datapoint, but it does not introduce new company fundamentals; any price effect is likely limited and short-lived.

02

Market read

Traders may monitor insider activity for sentiment, but the 10b5-1 pre-arrangement typically dampens interpretive impact.

03

What to watch

10b5-1 plans are often set months in advance; the sale amount may reflect diversification/tax planning rather than forward-looking expectations.

Relevance 6/10Novelty 5/10Timing: Filed today; sale executed 2026-06-04.

Background

This is an SEC Form 4 insider transaction disclosure for Vicor Corp (VICR).

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

VICR CEO/Chairman sold $507K of VICR shares via an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Low near-term impact; any reaction likely fades unless accompanied by other catalysts.

Evidence & confidence

The filing is a routine Form 4 datapoint (10b5-1 pre-arranged) with no accompanying company-specific operational or financial change.

Market effects

Minimal—single-company insider transaction with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

If market participants interpret the sale as confidence erosion, short-term selling pressure could occur despite the 10b5-1 label.

Key entities

  • VICR

    Vicor Corp; subject of the insider transaction disclosure.

  • VINCIARELLI PATRIZIO

    Chairman and CEO; executed an open-market sale under a pre-arranged 10b5-1 plan.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: